Emergent BioSolutions, Inc. (EBS)
7.995
-0.08
(-1.05%)
USD |
NYSE |
Mar 18, 15:59
8.01
+0.02
(+0.19%)
After-Hours: 20:00
Emergent BioSolutions Profit Margin (Quarterly) : -36.72% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp. | 12.68% |
| Eli Lilly & Co. | 34.40% |
| Penumbra, Inc. | 12.28% |
| Disc Medicine, Inc. | -- |
| MetaVia, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 9.83% |
| Return on Assets | 3.74% |
| Return on Invested Capital | 4.42% |
| Gross Profit Margin (Quarterly) | 31.34% |
| Operating Margin (Quarterly) | -11.16% |
| Return on Net Operating Assets | 4.49% |